Clinical Trials List
Protocol NumberAEGR-733-025
2015-03-01 - 2022-12-01
Others
Terminated2
-
Trial Applicant
CMIC Asia-Pacific
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
所有服用Lomitapid之患者皆須加入本試驗。 participants
-
Global
300 participants
